In the News
In a continuation of their trailblazing work, Peter Reese, MD, MSCE, and David Goldberg, MD, MSCE, report more encouraging results for patients who need transplants. A total of 20 have now successfully received hepatitis C positive kidneys plus antiviral therapy.
New research led by Vincent Lo Re III, MD, MSCE, shows that people with hepatitis C still frequently meet with insurance denials for once-a-day pills that became available in the United States in 2014 and have a 95 percent cure rate, with few side effects. Read more.
Providing aids such as nicotine patches and chewing gum doesn't help employees kick the smoking habit, and neither does giving them e-cigarettes, shows new research led by by Scott Halpern, MD, PhD. Supplementing the aids with financial incentives is three times more effective than giving them alone. Read more.